Researchers who analyzed the DNA of 280 patients with prostate cancer found that those who had abnormal levels of disturbances at chromosomal sites that are susceptible to DNA damage had a higher risk of cancer relapse, suggesting treatment failure. If validated in larger studies, the results could lead to the development of a test to help determine the best course of treatment.

Related Summaries